產(chǎn)品搜索
相關(guān)文章
- 實(shí)驗(yàn)?zāi)芊裰貜?fù)仍在持續(xù):誰(shuí)來(lái)給韓春雨事件畫上句號(hào)?
- 腫瘤細(xì)胞的熱敏感特性分析
- JCI:華人科學(xué)家發(fā)現(xiàn)促進(jìn)乳腺癌進(jìn)展轉(zhuǎn)移的表觀修飾閱讀者
- 有關(guān)細(xì)胞株生長(zhǎng)要考慮的因素
- *針對(duì)肝癌的PD-1抗體獲FDA批準(zhǔn),國(guó)產(chǎn)PD-1抗體進(jìn)入三期
- IL27細(xì)胞篩選模型
- 【藥靶模型】ESR1 Y537S模型開發(fā)
- 【新品上線】一種安全高效的中和抗體體外篩選模型
- 選擇進(jìn)口的細(xì)胞株這幾點(diǎn)千萬(wàn)不能忘!
- 【連載-Toll樣受體系列2】TLR7激動(dòng)劑藥物細(xì)胞篩選模型
聯(lián)系我們
電話:4008750250
號(hào)碼:
手機(jī):18066071954
地址:南京市棲霞區(qū)緯地路9號(hào)
Email: zhangxiangwen@cobioer.com
產(chǎn)品展示 / PRODUCTS
藥靶細(xì)胞株 > kinase激酶細(xì)胞株 > CBP73287BCR-ABL1 Y253H/BaF3激酶細(xì)胞株

- 詳細(xì)內(nèi)容
CBP73287 | |
I. Introduction | |
Cell Line Name: | BCR-ABL1 [Y253H]/BaF3 |
Host Cell: | Ba/F3 |
Stability: | 16 passages (in-house test, that not means the cell line will be instable beyond the passages we tested.) |
Application: | Anti-proliferation assay and PD assay |
Freeze Medium: | 90% FBS+10% DMSO |
Complete Culture Medium: | RPMI-1640+10%FBS |
Mycoplasma Status: | Negative |
II.Background | |
Presence of a BCR-ABL1 fusion gene is necessary for the pathogenesis of CML. In up to 95% of cases, a t(9;22) (q34;q11) translocation results in the BCR-ABL1 fusion gene (Faderl et al. 1999). This translocation results in the Philadephia chromosome. In rare CML cases lacking the traditional t(9;22) translocation, other translocations result in the creation of the BCR-ABL1 fusion gene, which sometimes involve multiple chromosomes. | |
III. Representative Data | |
1. WB of BCR-ABL1 [Y253H]/BaF3 | |
2.Sanger of BCR-ABL1 [Y253H]/BaF3 Figure 2. BCR-ABL1 Y253H Figure 3. BCR-ABL1 [Y253H]/BaF3 Fusion | |
3. Anti-proliferation assay Figure 4. CTG Proliferation Assay of BaF3 BCR-ABL1 Y253H Cells (C1). | |